Merck & Company, Inc. News Headlines

MRK 
$59.46
*  
0.49
0.83%
Get MRK Alerts
*Delayed - data as of May 27, 2015  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By







Bristol-Myers Squibb Will Prove To Be A Solid Investment
10/9/2013 2:04:00 PM - Seeking Alpha




Is Skin Cancer On The Way To Becoming A Curable Disease?
10/6/2013 7:16:00 AM - Seeking Alpha


Merck Streamlines Operations, Sacks 8,500 More Employees
10/3/2013 11:35:00 AM - Seeking Alpha


3 Cancer Investing Opportunities
10/1/2013 8:20:00 AM - Seeking Alpha




Does Conatus Pharmaceuticals Have A Winner With Emricasan?
9/25/2013 6:21:00 PM - Seeking Alpha




Searching For Yield With Bill Gross
9/25/2013 11:23:00 AM - Seeking Alpha


3 Biotech Stocks To Trade But For Different Reasons
9/24/2013 1:19:00 PM - Seeking Alpha




Amgen: US Filgrastim Patent Challenge
9/23/2013 11:18:00 AM - Seeking Alpha


Biotech Chimerix Lock-Up Expiration
9/23/2013 10:25:00 AM - Seeking Alpha






Eli Lilly And Merck: A Pipeline Of Success?
9/16/2013 3:57:00 PM - Seeking Alpha


Dividend Growth Investing: A Prospective Study
9/16/2013 2:32:00 PM - Seeking Alpha


Niraparib And Rolapitant Will Take Tesaro To New Heights
9/13/2013 3:21:00 PM - Seeking Alpha